Skip to main navigation
Skip to search
Skip to main content
University of Helsinki Home
English
Svenska
Suomi
Home
Persons
Publications
Projects
Research Infrastructures
Research Units
Datasets
Activities
Prizes
Press/Media
Search by expertise, name or affiliation
Prolyl oligopeptidase inhibitors – novel disease-modifying therapy for Parkinson’s disease?
Myöhänen, T.
(Speaker)
Faculty of Pharmacy
Division of Pharmacology and Pharmacotherapy
Drug Research Program
PREP in neurodegenerative disorders
Activity
:
Talk or presentation types
›
Oral presentation
Period
2016
Event title
Finnish Pharmacological Society symposium 2016
Event type
Conference
Location
Kuopio
Show on map
X